GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Position Lifted by AM Investment Strategies LLC

AM Investment Strategies LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 23,236 shares of the company’s stock after buying an additional 3,254 shares during the period. AM Investment Strategies LLC’s holdings in GE HealthCare Technologies were worth $1,797,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. First Command Advisory Services Inc. lifted its holdings in shares of GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after purchasing an additional 369 shares during the last quarter. Legacy Financial Group LLC bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. OFI Invest Asset Management bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. ORG Partners LLC lifted its holdings in shares of GE HealthCare Technologies by 174.2% in the 3rd quarter. ORG Partners LLC now owns 425 shares of the company’s stock worth $29,000 after purchasing an additional 270 shares during the last quarter. Finally, Fortitude Family Office LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $29,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC stock traded down $0.77 during mid-day trading on Thursday, hitting $85.95. 1,362,869 shares of the stock traded hands, compared to its average volume of 3,316,483. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The firm has a market cap of $39.22 billion, a price-to-earnings ratio of 28.46, a price-to-earnings-growth ratio of 3.00 and a beta of 0.94. The company’s 50-day simple moving average is $88.91 and its 200-day simple moving average is $78.32. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the firm earned $1.31 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.97%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on GEHC shares. Evercore ISI raised their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 target price on the stock. Argus lifted their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Finally, Mizuho lifted their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.